Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Curr Neurol Neurosci Rep ; 14(11): 495, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25218483

ABSTRACT

Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are characterized by the abnormal aggregation of a small number of intracellular proteins, with tau and α-synuclein being the most commonly affected. Until recently, the events leading to aggregate formation were believed to be entirely cell-autonomous, with protein misfolding occurring independently in many cells. It is now believed that protein aggregates form in a small number of brain cells, from which they propagate intercellularly through templated recruitment, reminiscent of the mechanisms by which prions spread through the nervous system.


Subject(s)
Central Nervous System/metabolism , Neurodegenerative Diseases/metabolism , Prions/metabolism , alpha-Synuclein/metabolism , tau Proteins/metabolism , Humans , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/pathology , Proteostasis Deficiencies/complications
2.
Brain Pathol ; 23(3): 342-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23587140

ABSTRACT

The soluble microtubule-associated protein tau forms hyperphosphorylated, insoluble and filamentous inclusions in a number of neurodegenerative diseases referred to as "tauopathies." In Alzheimer's disease, tau pathology develops in a stereotypical manner, with the first lesions appearing in the locus coeruleus and entorhinal cortex, from where they appear to spread to the hippocampus and neocortex. Propagation of tau pathology is also a characteristic of argyrophilic grain disease, where the tau lesions spread throughout the limbic system. Significantly, isoform composition and morphology of tau filaments can differ between tauopathies, suggesting the existence of distinct tau strains. Extensive experimental findings indicate that prion-like mechanisms underly the pathogenesis of tauopathies.


Subject(s)
Prion Diseases/metabolism , Proteostasis Deficiencies/metabolism , Tauopathies/metabolism , Animals , Humans , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/metabolism , Prion Diseases/genetics , Proteostasis Deficiencies/genetics , Proteostasis Deficiencies/therapy , Tauopathies/genetics , Tauopathies/therapy
SELECTION OF CITATIONS
SEARCH DETAIL